From Dionysus to Diagnosis

Substance Use Disorders and the Historical Formation of the Modern Self

To ask whether addiction is a timeless human weakness or a uniquely modern crisis is to ask a deeper question: has the structure of the self changed? Alcohol, opium, cannabis, and stimulants are not inventions of the industrial age. Fermentation predates writing. Opium circulated in ancient Mesopotamia. Cannabis traveled through Asia and the Mediterranean world. Yet what appears historically new is not intoxication itself, but the form through which we interpret, measure, and inhabit it.

Compulsive substance use is ancient. Substance Use Disorders, as medicalized, epidemiologically quantified, identity-forming categories, are modern. And their modern scale suggests something more than biology alone. It suggests a transformation in consciousness.

In the ancient Greek world, intoxication was symbolically mediated through the cult of Dionysus. Wine represented ecstasy, dissolution of boundaries, temporary participation in forces beyond the rational ego. Drinking was ritualized in the symposium, where wine was diluted and conversation structured. Excess was morally warned against, yet drunkenness did not crystallize into a diagnostic identity. A man might drink to excess; he did not become ontologically defined as diseased.

The absence of diagnosis in pre-modern societies was not ignorance; it reflected a different configuration of life. Identity was communal, not individual. Suffering was embedded within religious narrative. Excess was interpreted morally or spiritually, not neurologically. There was no statistical apparatus to track prevalence, no psychiatric manual to classify patterns, no neurochemical explanatory frame to reframe vice as disorder. Intoxication occurred within containment structures—ritual, community, theology—that buffered the individual from isolation.

The transition begins in the nineteenth century. Industrialization fractures village life. Urbanization dissolves communal bonds. Time becomes mechanical rather than liturgical. Distilled spirits proliferate. Within this context, the Swedish physician Magnus Huss introduces the term “alcoholism” in 1849, reframing chronic intoxication as medical pathology rather than moral failure.¹ In the twentieth century, E. M. Jellinek formalizes typologies of alcohol dependence, arguing that alcoholism follows discernible patterns of progression.² The founding of Alcoholics Anonymous in 1935 simultaneously medicalizes and spiritualizes addiction, recasting it as disease while preserving the language of surrender and transformation.³

This transformation parallels a broader shift: the rise of statistical governance. Modern states do not merely punish or moralize; they measure. Behavior becomes data. Populations become epidemiological categories. Individuals become diagnosable units within surveillance systems. Addiction becomes not only an act but a measurable identity.

The modern scale of Substance Use Disorders confirms the transformation. According to the 2023–2024 National Survey on Drug Use and Health (NSDUH), approximately 48.4 million Americans aged 12 or older met criteria for a Substance Use Disorder in the past year, representing roughly 17 percent of that population.⁴ Of these, 27.9 million had Alcohol Use Disorder and 28.2 million had Drug Use Disorder.⁴ These numbers are not incidental fluctuations; they describe a population-level phenomenon.

Alcohol alone contributes to approximately 178,000 deaths annually in the United States, making it one of the leading preventable causes of death (CDC, 2024, p. 3).⁵ Drug overdose deaths exceeded 105,000 in 2023, reflecting a dramatic escalation over the past two decades (CDC National Center for Health Statistics, 2024, p. 1).⁶ Globally, the World Health Organization estimates that alcohol contributes to approximately 2.6 million deaths per year worldwide (WHO, 2023, p. 21).⁷ In the WHO European Region alone, alcohol accounts for roughly 800,000 deaths annually, representing nearly one in eleven deaths (WHO Europe, 2023, p. 5).⁸

These figures do not merely quantify behavior; they reveal a structural condition. Pre-modern societies did not track prevalence at this scale. They lacked both the institutional machinery and the conceptual framework for doing so. The emergence of population-level addiction statistics marks a new form of self-understanding: the self as epidemiological subject.

Why does Europe’s statistical landscape appear different from that of the United States? The divergence reflects governance structure rather than absence of disorder. In the United States, agencies such as SAMHSA and the CDC centralize surveillance. In Europe, addiction data are coordinated through the European Union Drugs Agency (formerly EMCDDA) alongside national reporting systems.⁹ Definitions, methodologies, and reporting intervals vary across member states. The European model emphasizes harm reduction, treatment access, and public health integration, sometimes producing less centralized datasets but not less prevalence.¹⁰ The mosaic of European data reflects decentralized governance, not cultural immunity.

Yet numbers alone do not explain causation. They measure magnitude; they do not interpret meaning.

Modernity produces radical individualization. Religious teleology weakens. Ritual time dissolves. Identity becomes reflexive and psychological rather than inherited and communal. The individual becomes sovereign—and exposed. In such a condition, repetitive behavior acquires existential weight. Substances no longer mediate between human and divine; they mediate between self and emptiness.

Addiction may therefore be understood as both biological vulnerability and historical adaptation. Neurochemical reinforcement is ancient. But its contemporary proliferation, chronicity, and identity-fusion belong to a world in which individuals must metabolize meaning alone. When cosmic frameworks recede, anesthesia becomes attractive. When ritual containment collapses, private repetition intensifies.

To reduce addiction to brain chemistry ignores its historical escalation. To reduce it to social construction ignores its biological substrate. The more rigorous conclusion is synthetic: biological susceptibility is perennial; modern conditions intensify exposure; statistical governance crystallizes identity; and addiction emerges as both medical disorder and historical symptom.

In medieval Europe, scripture revealed invisible metaphysical realities. Today, statistics reveal invisible population realities. They function as secular revelation. But revelation requires interpretation. The numbers tell us how many are afflicted; history tells us why the category itself came into being.

From Dionysus to diagnosis, from myth to measurement, addiction tracks the transformation of the Western self. The substances remain. The interpretive world has changed. And within that change, the modern epidemic of Substance Use Disorders finds both its measurable scale and its historical meaning.

---

References

1. Huss, M. (1852). Alcoholismus Chronicus (original publication 1849).
2. Jellinek, E. M. (1960). The Disease Concept of Alcoholism. New Haven: Hillhouse Press.
3. Alcoholics Anonymous. (1939). Alcoholics Anonymous: The Story of How More Than One Hundred Men Have Recovered from Alcoholism.
4. Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey on Drug Use and Health, 2023–2024 Annual Report, pp. 12–15.
5. Centers for Disease Control and Prevention (CDC). Alcohol-Related Deaths — United States, 2024, p. 3.
6. CDC National Center for Health Statistics. Drug Overdose Deaths in the United States, 2023, Data Brief No. 522, p. 1.
7. World Health Organization (WHO). Global Status Report on Alcohol and Health 2023, p. 21.
8. WHO Regional Office for Europe. Alcohol in the WHO European Region: Status Report 2023, p. 5.
9. European Union Drugs Agency (EUDA). European Drug Report 2025, Overview Section, pp. 7–10.
10. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Statistical Bulletin 2024, Methodology Notes, pp. 2–4.

Brenton L. Delp MFT